HEMATOLOGY

Latest News

FDA Accepts Remestemcel-L BLA Resubmission for Acute GVHD
FDA Accepts Remestemcel-L BLA Resubmission for Acute GVHD

July 23rd 2024

The FDA has accepted the resubmitted application of remestemcel-L, a potential first-of-its-kind treatment for pediatric patients following stem cell transplants.

FDA Grants Rare Pediatric Disease Designation to SLS009 in Pediatric AML
FDA Grants Rare Pediatric Disease Designation to SLS009 in Pediatric AML

July 16th 2024

FDA Enforces Partial Hold on Trial of Seclidemstat in MDS/CMML
FDA Enforces Partial Hold on Trial of Seclidemstat in MDS/CMML

July 16th 2024

FDA Fast Tracks DSP-5336 in NPM1/KMT2A+ Acute Leukemia
FDA Fast Tracks DSP-5336 in NPM1/KMT2A+ Acute Leukemia

July 15th 2024

FDA Wraps Up End Of Phase 2 Meeting for AML Combination Therapy
FDA Wraps Up End Of Phase 2 Meeting for AML Combination Therapy

July 10th 2024

More News